Home
Data
Calendar
Blog
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 60.60 | 60.34 | 58.72 | NA | 52.35 | 46.96 | 46.50 | NA | 46.16 | 46.12 | NA | NA | 37.88 | 31.78 | NA | NA | 22.95 | 22.93 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 60.60 | 60.34 | 58.72 | NA | 52.35 | 46.96 | 46.50 | NA | 46.16 | 46.12 | NA | NA | 36.89 | 29.90 | NA | NA | 22.95 | 22.93 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | NA | NA | NA | NA | NA | NA | 46.50 | NA | NA | NA | 45.91 | NA | NA | NA | 23.20 | NA | 22.95 | 22.93 | 22.87 | NA | 0.48 | 0.48 | 0.47 | NA | 0.45 | NA | NA | |
| Earnings Per Share Basic | -0.81 | -0.64 | -0.85 | -0.61 | -0.37 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | NA | -1.48 | 0.46 | 1.00 | -0.84 | NA | -0.56 | -0.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Diluted | -0.81 | -0.64 | -0.85 | -0.61 | -0.37 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | NA | -1.48 | 0.45 | 0.94 | -0.84 | NA | -0.56 | -0.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic And Diluted | NA | NA | NA | NA | NA | NA | -0.84 | NA | NA | NA | -0.66 | NA | NA | NA | -0.84 | -0.65 | -0.56 | -0.60 | -0.62 | -0.07 | -21.26 | -24.17 | -25.76 | -33.51 | -3.14 | -4.07 | -2.55 |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 16.92 | 10.41 | 12.67 | 8.63 | 25.15 | 28.10 | 5.90 | 10.65 | 8.52 | 28.05 | 14.66 | 8.28 | 17.82 | 9.47 | 7.15 | 11.30 | 12.28 | 10.53 | 8.63 | 19.09 | 7.84 | 5.70 | 5.79 | 4.04 | 17.50 | 15.36 | 14.85 | |
| Revenues | 16.92 | 10.41 | 12.67 | 8.63 | 25.15 | 28.10 | 5.90 | 10.65 | 8.52 | 28.05 | 14.66 | 8.28 | 17.82 | 9.47 | 7.15 | 11.30 | 12.28 | 10.53 | 8.63 | 19.09 | 7.84 | 5.70 | 5.79 | 4.04 | 17.50 | 15.36 | 14.85 | |
| Operating Expenses | 60.94 | 56.59 | 54.91 | 57.85 | 46.36 | 47.48 | 45.03 | 45.69 | 43.19 | 37.85 | 33.67 | 33.12 | 28.44 | 25.89 | 26.33 | 26.09 | 25.01 | 24.21 | 22.89 | 22.36 | 17.99 | 17.79 | 17.50 | 19.21 | 18.56 | NA | NA | |
| Research And Development Expense | 45.67 | 41.59 | 39.40 | 43.13 | 31.71 | 32.33 | 29.99 | 29.93 | 26.60 | 25.31 | 22.56 | 22.74 | 19.36 | 17.24 | 17.62 | 17.39 | 16.90 | 16.14 | 15.18 | 14.79 | 12.64 | 13.75 | 13.08 | 15.14 | 13.67 | NA | NA | |
| General And Administrative Expense | 15.27 | 15.00 | 15.51 | 14.72 | 14.64 | 15.14 | 15.04 | 15.76 | 16.59 | 12.54 | 11.11 | 10.38 | 9.08 | 8.64 | 8.71 | 8.70 | 8.12 | 8.07 | 7.71 | 7.57 | 5.35 | 4.04 | 4.41 | 4.07 | 4.89 | NA | NA | |
| Operating Income Loss | -44.01 | -46.18 | -42.24 | -49.22 | -21.21 | -19.38 | -39.13 | -35.04 | -34.67 | -9.80 | -19.01 | -24.84 | -10.62 | -16.42 | -19.18 | -14.78 | -12.73 | -13.69 | -14.27 | -3.27 | -10.16 | -12.09 | -11.70 | -15.17 | -1.06 | NA | NA | |
| Interest Expense Debt | 0.30 | 0.40 | 0.50 | 0.60 | 0.60 | 0.60 | 0.70 | 0.70 | 0.70 | 0.60 | 0.60 | 0.60 | 0.70 | 0.60 | 0.20 | 0.20 | 0.30 | 0.30 | 0.40 | 0.70 | 0.30 | 0.30 | 0.40 | NA | NA | NA | NA | |
| Interest Paid Net | 0.25 | 0.33 | 0.39 | 0.43 | 0.44 | 0.49 | 0.50 | 0.51 | 0.52 | 0.69 | 0.33 | 0.51 | 0.52 | 0.52 | 0.13 | 0.15 | 0.27 | 0.30 | 0.33 | 0.33 | 0.33 | 0.32 | 0.30 | 0.29 | NA | NA | NA | |
| Allocated Share Based Compensation Expense | 6.00 | 6.66 | 6.02 | 5.85 | 6.78 | 6.70 | 6.97 | 6.89 | 6.50 | 5.91 | 3.95 | 3.09 | 3.11 | 3.01 | 2.71 | 10.30 | 0.00 | 0.00 | 0.00 | 2.87 | 0.00 | 0.00 | 0.00 | 1.39 | 0.00 | NA | NA | |
| Income Tax Expense Benefit | 1.84 | 0.20 | 0.40 | 0.00 | 0.00 | 2.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Profit Loss | -49.28 | -38.52 | -50.05 | -34.59 | -19.49 | -26.01 | -39.11 | -38.12 | -30.90 | -6.15 | -30.36 | -59.54 | 17.14 | 29.87 | -19.59 | -14.79 | -12.91 | -13.79 | -14.25 | -1.49 | -10.24 | -11.54 | -12.05 | -15.34 | NA | NA | NA | |
| Net Income Loss | -49.28 | -38.52 | -50.05 | -34.59 | -19.49 | -26.01 | -39.11 | -38.12 | -30.90 | -6.15 | -30.36 | -59.54 | 17.14 | 29.87 | -19.59 | -14.79 | -12.91 | -13.79 | -14.25 | -1.49 | -10.24 | -11.54 | -12.05 | -15.34 | -1.42 | -1.81 | -1.11 | |
| Comprehensive Income Net Of Tax | -49.29 | -38.40 | -49.54 | -33.88 | -19.47 | -26.22 | -39.95 | -38.41 | -30.89 | -6.20 | -30.49 | -59.65 | 16.98 | 30.24 | -19.73 | -14.85 | -12.90 | -13.64 | -14.15 | -1.51 | -10.26 | -11.54 | -12.05 | -15.34 | -1.41 | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 431.73 | 464.90 | 358.02 | 406.94 | 400.70 | 385.62 | 303.68 | 341.41 | 371.47 | 359.79 | 358.53 | 394.11 | 307.24 | 277.54 | 153.88 | 156.37 | 171.68 | 188.81 | 202.46 | 223.14 | 145.03 | NA | NA | 40.77 | NA | NA | NA | |
| Liabilities | 319.39 | 310.18 | 172.60 | 189.90 | 170.97 | 176.56 | 83.30 | 88.84 | 87.89 | 52.29 | 51.19 | 62.06 | 63.12 | 70.78 | 71.79 | 58.58 | 61.77 | 69.26 | 71.74 | 91.60 | 99.21 | NA | NA | 47.27 | NA | NA | NA | |
| Liabilities And Stockholders Equity | 431.73 | 464.90 | 358.02 | 406.94 | 400.70 | 385.62 | 303.68 | 341.41 | 371.47 | 359.79 | 358.53 | 394.11 | 307.24 | 277.54 | 153.88 | 156.37 | 171.68 | 188.81 | 202.46 | 223.14 | 145.03 | NA | NA | 40.77 | NA | NA | NA | |
| Stockholders Equity | 112.35 | 154.72 | 185.41 | 217.05 | 229.73 | 209.06 | 220.37 | 252.56 | 283.58 | 307.50 | 307.34 | 332.05 | 244.12 | 206.76 | 82.08 | 97.79 | 109.91 | 119.56 | 130.72 | 131.54 | -141.43 | -132.02 | -120.75 | -109.00 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 381.25 | 411.99 | 304.06 | 353.15 | 346.55 | 331.51 | 228.74 | 218.51 | 250.73 | 277.62 | 266.00 | 378.18 | 292.30 | 258.49 | 127.46 | 128.57 | 135.57 | 162.22 | 176.53 | 209.95 | 127.37 | NA | NA | 25.63 | NA | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 81.83 | 235.09 | 62.47 | 47.25 | 96.78 | 79.11 | 28.90 | 30.41 | 30.71 | 56.39 | 55.82 | 206.15 | 64.37 | 65.35 | 43.56 | 4.96 | 11.95 | 19.39 | 26.62 | 125.30 | 41.35 | 25.42 | 6.63 | 22.02 | 25.41 | NA | NA | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 82.71 | 235.97 | 63.34 | 48.13 | 97.65 | 79.99 | 29.77 | 31.29 | 31.58 | 57.26 | 56.69 | 207.02 | 65.24 | 65.36 | 43.58 | 4.97 | 11.97 | 19.41 | 26.63 | 125.31 | 41.37 | 25.43 | 6.65 | 22.04 | 25.42 | NA | NA | |
| Marketable Securities Current | 239.27 | 123.20 | 188.99 | 255.09 | 190.56 | 112.51 | 142.50 | 130.34 | 159.23 | 167.03 | 164.46 | 120.34 | 137.99 | 136.01 | 71.83 | 112.90 | 113.21 | 133.77 | 143.95 | 79.19 | NA | NA | NA | NA | NA | NA | NA | |
| Accounts Receivable Net Current | 16.63 | 10.00 | 9.87 | 7.12 | 11.24 | 97.67 | 11.69 | 12.45 | 12.33 | 9.16 | 7.23 | 5.56 | 7.48 | 5.10 | 9.08 | 6.30 | 7.53 | 6.50 | 3.34 | 2.49 | 2.44 | NA | NA | 1.62 | NA | NA | NA | |
| Prepaid Expense And Other Assets Current | 9.48 | 10.34 | 17.70 | 11.67 | 11.06 | 8.20 | 7.91 | 8.12 | 8.70 | 9.75 | 7.55 | 4.49 | 3.58 | 2.93 | 2.99 | 4.41 | 2.87 | 2.56 | 2.63 | 2.96 | 1.98 | NA | NA | 1.99 | NA | NA | NA | |
| Equity Securities Fv Ni | 34.04 | 33.35 | 25.03 | 32.02 | 36.91 | 34.01 | 37.74 | 37.18 | 39.76 | 35.28 | 30.95 | 41.64 | 78.87 | 49.09 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Available For Sale Securities Debt Securities | 318.99 | 357.81 | 250.10 | 298.41 | 286.45 | 182.68 | 191.56 | 228.57 | 253.62 | 285.00 | 292.85 | 324.97 | 201.88 | 204.89 | 127.49 | 131.66 | 148.85 | 166.04 | 184.42 | 195.40 | 123.22 | NA | NA | 18.96 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | NA | NA | NA | 62.53 | NA | NA | NA | 55.98 | NA | NA | NA | 49.76 | NA | NA | NA | 43.48 | NA | NA | NA | 40.23 | NA | NA | NA | 39.01 | NA | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | NA | NA | 37.91 | NA | NA | NA | 33.43 | NA | NA | NA | 36.83 | NA | NA | NA | 33.85 | NA | NA | NA | 29.30 | NA | NA | NA | 25.01 | NA | NA | NA | |
| Property Plant And Equipment Net | 22.34 | 23.64 | 24.03 | 24.62 | 24.28 | 23.60 | 23.29 | 22.55 | 23.32 | 18.67 | 14.83 | 12.94 | 11.95 | 11.27 | 9.53 | 9.63 | 8.52 | 9.27 | 9.93 | 10.93 | 11.67 | NA | NA | 14.00 | NA | NA | NA | |
| Other Assets Noncurrent | 3.27 | 3.27 | 3.25 | 1.85 | 1.92 | 1.92 | 1.71 | 1.66 | 2.14 | 2.63 | 2.21 | 2.12 | 2.12 | 2.12 | 2.68 | 2.54 | 2.35 | 2.24 | 2.23 | 2.24 | 5.97 | NA | NA | 1.13 | NA | NA | NA | |
| Equity Securities Fv Ni | 34.04 | 33.35 | 25.03 | 32.02 | 36.91 | 34.01 | 37.74 | 37.18 | 39.76 | 35.28 | 30.95 | 41.64 | 78.87 | 49.09 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Available For Sale Debt Securities Amortized Cost Basis | 318.98 | 357.79 | 250.20 | 299.03 | 287.79 | 184.03 | 192.71 | 228.88 | 253.65 | 285.05 | 292.85 | 324.85 | 201.65 | 204.49 | 127.46 | 131.50 | 148.62 | 165.83 | 184.37 | 195.44 | 123.25 | NA | NA | 18.96 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 73.61 | 67.12 | 59.49 | 66.55 | 58.29 | 44.57 | 38.76 | 41.74 | 35.45 | 26.12 | 22.66 | 29.60 | 29.91 | 35.46 | 32.01 | 32.97 | 35.86 | 36.10 | 31.13 | 36.42 | 36.91 | NA | NA | 31.96 | NA | NA | NA | |
| Debt Current | 7.14 | 10.20 | 13.24 | 12.50 | 12.50 | 12.50 | 12.50 | 9.38 | 6.25 | 3.12 | NA | NA | NA | NA | NA | 1.00 | 5.84 | 5.81 | 5.77 | 4.72 | 3.18 | NA | NA | 14.63 | NA | NA | NA | |
| Long Term Debt Current | NA | NA | NA | 12.50 | NA | NA | NA | 9.38 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Accounts Payable Current | 5.53 | 3.86 | 5.06 | 4.80 | 12.44 | 12.57 | 10.71 | 11.33 | 11.17 | 7.64 | 5.89 | 5.54 | 4.88 | 4.90 | 5.84 | 5.58 | 4.55 | 4.52 | 3.40 | 3.06 | 4.59 | NA | NA | 2.90 | NA | NA | NA | |
| Accrued Liabilities Current | 11.37 | 9.51 | 6.36 | 13.14 | 10.38 | 7.75 | 5.41 | 11.42 | 8.49 | 6.51 | 4.50 | 8.82 | 5.89 | 4.52 | 2.94 | 6.02 | 4.63 | 3.56 | 2.50 | 6.22 | 4.08 | NA | NA | 3.64 | NA | NA | NA | |
| Other Liabilities Current | 3.04 | 7.33 | 2.19 | 3.08 | 4.41 | 4.15 | 2.79 | 3.08 | 0.30 | 0.72 | 0.18 | 0.63 | 3.44 | 2.54 | 0.35 | 0.90 | 0.59 | 0.83 | 0.44 | 0.85 | 0.81 | NA | NA | 0.07 | NA | NA | NA | |
| Contract With Customer Liability Current | 23.98 | 18.04 | 17.19 | 16.76 | 15.92 | 6.49 | 6.28 | 5.50 | 7.80 | 8.13 | 12.09 | 14.60 | 15.70 | 23.50 | 22.87 | 19.46 | 20.25 | 21.38 | 19.02 | 21.57 | NA | NA | NA | 10.71 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long Term Debt | NA | NA | NA | 16.27 | NA | NA | NA | 25.11 | NA | NA | NA | 24.55 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Long Term Debt Noncurrent | NA | NA | NA | 3.77 | 6.78 | 9.78 | 12.76 | 15.74 | 18.71 | 21.69 | 24.68 | 24.55 | 24.41 | 24.28 | 24.16 | 8.88 | 5.50 | 7.00 | 8.50 | 10.00 | 11.50 | NA | NA | NA | NA | NA | NA | |
| Other Liabilities Noncurrent | NA | NA | NA | 0.12 | 0.13 | 0.14 | 0.15 | 0.15 | 1.50 | 0.84 | 0.64 | 0.48 | 0.15 | 0.15 | 0.14 | 0.13 | 0.13 | 0.12 | 0.12 | 0.10 | 0.66 | NA | NA | 0.01 | NA | NA | NA | |
| Operating Lease Liability Noncurrent | 24.86 | 26.53 | 28.07 | 29.57 | 31.04 | 32.07 | 31.63 | 31.22 | 32.07 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 112.35 | 154.72 | 185.41 | 217.05 | 229.73 | 209.06 | 220.37 | 252.56 | 283.58 | 307.50 | 307.34 | 332.05 | 244.12 | 206.76 | 82.08 | 97.79 | 109.91 | 119.56 | 130.72 | 131.54 | -141.43 | -132.02 | -120.75 | -109.00 | NA | NA | NA | |
| Common Stock Value | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | NA | NA | NA | NA | NA | NA | NA | |
| Additional Paid In Capital Common Stock | 702.75 | 695.83 | 688.12 | 670.22 | 649.03 | 608.90 | 594.00 | 586.24 | 578.85 | 571.88 | 565.52 | 559.75 | 412.17 | 391.79 | 297.37 | 293.35 | 290.62 | 287.36 | 284.89 | 281.89 | 7.43 | NA | NA | 6.22 | NA | NA | NA | |
| Retained Earnings Accumulated Deficit | -590.47 | -541.19 | -502.67 | -452.62 | -418.02 | -398.53 | -372.52 | -333.41 | -295.29 | -264.38 | -258.23 | -227.87 | -168.33 | -185.47 | -215.34 | -195.75 | -180.96 | -168.04 | -154.25 | -150.33 | -148.84 | NA | NA | -115.01 | NA | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0.01 | 0.02 | -0.11 | -0.62 | -1.34 | -1.36 | -1.15 | -0.31 | -0.03 | -0.04 | NA | 0.13 | 0.24 | 0.40 | 0.03 | 0.17 | 0.22 | 0.21 | 0.06 | -0.05 | NA | NA | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 6.00 | 6.66 | 6.02 | NA | 6.78 | 6.70 | 6.97 | NA | 6.50 | 5.91 | 3.95 | NA | 3.11 | 3.01 | 2.71 | NA | 2.88 | 2.46 | 2.29 | NA | 0.32 | 0.23 | 0.25 | NA | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -33.50 | -31.20 | -60.99 | -23.86 | 65.85 | -3.19 | -35.26 | -21.58 | -24.41 | -5.26 | -30.43 | -18.88 | -17.69 | -12.50 | -18.73 | -13.16 | -16.12 | -15.60 | -20.14 | -5.93 | 47.57 | -13.95 | -15.01 | -4.84 | NA | NA | NA | |
| Net Cash Provided By Used In Investing Activities | -114.02 | 66.16 | 67.45 | -37.88 | -78.04 | 47.91 | 32.98 | 20.78 | -2.24 | 5.88 | -121.73 | 15.81 | 0.30 | -57.14 | 41.64 | 7.94 | 9.81 | 9.19 | -78.08 | 2.02 | -81.81 | -0.04 | -0.36 | 1.63 | NA | NA | NA | |
| Net Cash Provided By Used In Financing Activities | -5.74 | 137.66 | 8.76 | 12.22 | 29.85 | 5.49 | 0.76 | 0.51 | 0.96 | -0.04 | 1.83 | 144.85 | 17.27 | 91.42 | 15.70 | -1.78 | -1.13 | -0.82 | -0.46 | 87.86 | 50.17 | 32.77 | -0.01 | -0.18 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -33.50 | -31.20 | -60.99 | -23.86 | 65.85 | -3.19 | -35.26 | -21.58 | -24.41 | -5.26 | -30.43 | -18.88 | -17.69 | -12.50 | -18.73 | -13.16 | -16.12 | -15.60 | -20.14 | -5.93 | 47.57 | -13.95 | -15.01 | -4.84 | NA | NA | NA | |
| Net Income Loss | -49.28 | -38.52 | -50.05 | -34.59 | -19.49 | -26.01 | -39.11 | -38.12 | -30.90 | -6.15 | -30.36 | -59.54 | 17.14 | 29.87 | -19.59 | -14.79 | -12.91 | -13.79 | -14.25 | -1.49 | -10.24 | -11.54 | -12.05 | -15.34 | -1.42 | -1.81 | -1.11 | |
| Profit Loss | -49.28 | -38.52 | -50.05 | -34.59 | -19.49 | -26.01 | -39.11 | -38.12 | -30.90 | -6.15 | -30.36 | -59.54 | 17.14 | 29.87 | -19.59 | -14.79 | -12.91 | -13.79 | -14.25 | -1.49 | -10.24 | -11.54 | -12.05 | -15.34 | NA | NA | NA | |
| Depreciation Depletion And Amortization | 1.74 | 1.73 | 1.61 | 1.53 | 1.44 | 1.40 | 1.33 | 1.31 | 1.12 | 1.12 | 1.29 | 1.17 | 0.97 | 1.06 | 1.10 | 1.22 | 1.23 | 1.19 | 1.14 | 1.14 | 1.12 | 1.12 | 1.16 | 1.19 | NA | NA | NA | |
| Increase Decrease In Accounts Receivable | 6.63 | 0.13 | 2.75 | -4.13 | -86.43 | 85.98 | -0.77 | 0.12 | 3.17 | 1.93 | 1.67 | -1.92 | 2.38 | -3.98 | 2.78 | -1.23 | 1.03 | 3.16 | 0.85 | 0.05 | -0.74 | -0.97 | 2.53 | -9.23 | NA | NA | NA | |
| Increase Decrease In Accounts Payable | 1.41 | -0.86 | 0.20 | -0.94 | -1.12 | 1.97 | -1.13 | 1.95 | 2.74 | 2.20 | -0.46 | -0.23 | 1.25 | NA | NA | 0.78 | 0.17 | 0.83 | 0.48 | 0.34 | 0.52 | -0.46 | -0.19 | -0.65 | NA | NA | NA | |
| Share Based Compensation | 6.00 | 6.66 | 6.02 | 5.85 | 6.78 | 6.70 | 6.97 | 6.89 | 6.50 | 5.91 | 3.95 | 3.09 | 3.11 | 3.01 | 2.71 | 2.68 | 2.88 | 2.46 | 2.29 | 2.07 | 0.32 | 0.22 | 0.26 | 0.27 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | -114.02 | 66.16 | 67.45 | -37.88 | -78.04 | 47.91 | 32.98 | 20.78 | -2.24 | 5.88 | -121.73 | 15.81 | 0.30 | -57.14 | 41.64 | 7.94 | 9.81 | 9.19 | -78.08 | 2.02 | -81.81 | -0.04 | -0.36 | 1.63 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -5.74 | 137.66 | 8.76 | 12.22 | 29.85 | 5.49 | 0.76 | 0.51 | 0.96 | -0.04 | 1.83 | 144.85 | 17.27 | 91.42 | 15.70 | -1.78 | -1.13 | -0.82 | -0.46 | 87.86 | 50.17 | 32.77 | -0.01 | -0.18 | NA | NA | NA |
| 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 16.92 | 10.41 | 12.67 | 8.63 | 25.15 | 28.10 | 5.90 | 10.65 | 8.52 | 28.05 | 14.66 | 8.28 | 17.82 | 9.47 | 7.15 | 11.30 | 12.28 | 10.53 | 8.63 | 19.09 | 7.84 | 5.70 | 5.79 | 4.04 | 17.50 | 15.36 | 14.85 | |
| Materials Supply, Bms Agreement And Two Thousand Eighteen Bms Master Services Agreement | 0.19 | 2.04 | 2.94 | 0.87 | 4.24 | 2.03 | 1.92 | 3.52 | 0.87 | 5.22 | 0.94 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Services, Bms Agreement And Two Thousand Eighteen Bms Master Services Agreement | 0.00 | 0.19 | 0.22 | 0.11 | 0.11 | 0.24 | 0.24 | 0.18 | 0.25 | 0.21 | 0.30 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Bms Agreement And Two Thousand Eighteen Bms Master Services Agreement | 0.19 | 2.24 | 3.17 | 0.98 | 4.34 | 2.27 | 2.17 | 3.70 | 1.12 | 5.43 | 1.24 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 16.92 | 10.41 | 12.67 | 8.63 | 25.15 | 28.10 | 5.90 | 10.65 | 8.52 | 28.05 | 14.66 | 8.28 | 17.82 | 9.47 | 7.15 | 11.30 | 12.28 | 10.53 | 8.63 | 19.09 | 7.84 | 5.70 | 5.79 | 4.04 | 17.50 | 15.36 | 14.85 | |
| Vaxcyte Inc, Materials Supply, Supply Agreement | 0.96 | 0.14 | 0.17 | 0.45 | 0.84 | 0.01 | 0.17 | 0.20 | 0.49 | 0.10 | 1.11 | -0.26 | 0.14 | 0.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Vaxcyte Inc, Research And Development Services, Supply Agreement | 0.64 | 0.57 | 0.50 | 0.56 | 0.65 | 0.54 | 0.60 | 0.41 | 0.25 | 0.26 | 0.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Astellas Pharma Inc Astellas, Collaboration And License Agreements And Supply Agreements | 9.99 | 7.33 | 6.27 | 5.91 | 4.99 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Bionova Pharmaceuticals Ltd Bionova, Collaboration And License Agreements And Supply Agreements | NA | NA | NA | 0.00 | 4.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Merck K Ga A Darmstadt Germany, Collaboration And License Agreements And Supply Agreements | 0.00 | 0.00 | 0.01 | 0.49 | 0.17 | 0.14 | 1.90 | 1.73 | 0.25 | 2.38 | 0.22 | 0.39 | 1.51 | 0.85 | 2.29 | 0.73 | 2.65 | 3.36 | 2.14 | 1.75 | 1.75 | 1.97 | 1.71 | NA | NA | NA | NA | |
| Merck Sharp And Dohme Corporation, Collaboration And License Agreements And Supply Agreements | 0.08 | 0.14 | 2.55 | 0.23 | 10.16 | 0.15 | 1.06 | 4.61 | 6.41 | 19.88 | 11.88 | 7.24 | 9.05 | 7.00 | 2.78 | 5.84 | 5.49 | 5.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Tasly Biopharmaceuticals Co Ltd, Collaboration And License Agreements And Supply Agreements | 5.07 | NA | NA | 0.00 | 0.00 | 25.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Vaxcyte Inc, Collaboration And License Agreements And Supply Agreements | 1.59 | 0.70 | 0.68 | 1.01 | 1.50 | 0.55 | 0.77 | 0.62 | 0.74 | 0.37 | 1.32 | -0.08 | 0.14 | 0.10 | 0.04 | 0.01 | 0.79 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Vaxcyte Inc, Supply Agreement | 1.59 | 0.70 | 0.68 | 1.01 | 1.50 | 0.55 | 0.77 | 0.62 | 0.74 | 0.37 | 1.32 | -0.08 | 0.14 | 0.10 | 0.04 | -0.02 | 0.80 | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Contingent Payment, Tasly License Agreement | 5.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Contingent Payment, Two Thousand Twenty Merck Master Services Agreement | NA | NA | NA | NA | 10.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Contingent Payment Earned, Two Thousand Twenty Merck Master Services Agreement | NA | NA | NA | 0.00 | 10.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Financing Component On Unearned Revenue, Astellas License And Collaboration Agreement | 2.46 | 2.53 | 2.54 | 2.83 | 2.25 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Materials Supply, Two Thousand Nineteen E M D Serono Supply Agreements | 0.00 | 0.00 | 0.00 | 0.48 | 0.09 | 0.01 | 1.61 | 1.38 | 0.04 | 0.25 | 0.06 | 0.16 | 0.24 | 0.36 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Materials Supply, Two Thousand Twenty Merck Master Services Agreement | 0.06 | 0.06 | 2.43 | 0.06 | 0.02 | 0.05 | 0.03 | 0.01 | 2.34 | 0.67 | 1.39 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ongoing Performance Related To Unsatisfied Performance Obligations, Astellas License And Collaboration Agreement | 5.61 | 3.24 | 2.57 | 2.02 | 1.93 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Ongoing Performance Related To Unsatisfied Performance Obligations, Two Thousand Twenty Merck Master Services Agreement | NA | NA | NA | 0.00 | 0.00 | 0.00 | 0.86 | 4.21 | 3.51 | 18.32 | 9.06 | 5.43 | 6.91 | 5.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Services, Astellas License And Collaboration Agreement | 1.92 | 1.56 | 1.16 | 1.07 | 0.81 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Services, Tasly License Agreement | 0.07 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Services, Two Thousand Nineteen E M D Serono Supply Agreements | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.13 | 0.28 | 0.35 | 0.21 | 0.13 | 0.16 | 0.23 | 0.27 | 0.49 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Research And Development Services, Two Thousand Twenty Merck Master Services Agreement | 0.02 | 0.08 | 0.12 | 0.17 | 0.14 | 0.09 | 0.17 | 0.34 | 0.42 | 0.70 | 1.21 | 1.24 | 1.73 | 1.27 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Bristol Myers Squibb Company B M S, Collaboration And License Agreements And Supply Agreements | 0.19 | 2.24 | 3.17 | 0.98 | 4.34 | 2.27 | 2.17 | 3.70 | 1.12 | 5.43 | 1.24 | 0.73 | 7.12 | 1.51 | 2.04 | 4.72 | 3.35 | 1.67 | 1.57 | NA | NA | NA | NA | NA | NA | NA | NA | |
| Astellas License And Collaboration Agreement | 9.99 | 7.33 | 6.27 | 5.91 | 4.99 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Collaboration And License Agreements And Supply Agreements | 16.92 | 10.41 | 12.67 | 8.63 | 25.15 | 28.10 | 5.90 | 10.65 | 8.52 | 28.05 | 14.66 | 8.28 | 17.82 | 9.47 | 7.15 | 11.30 | 12.28 | 10.53 | 8.63 | 19.09 | 7.84 | 5.70 | 5.79 | NA | NA | NA | NA | |
| Tasly License Agreement | 5.07 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Two Thousand Nineteen E M D Serono Supply Agreements | 0.00 | 0.00 | 0.01 | 0.49 | 0.17 | 0.14 | 1.90 | 1.73 | 0.25 | 2.38 | 0.22 | 0.39 | 1.51 | 0.85 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Two Thousand Twenty Merck Master Services Agreement | 0.08 | 0.14 | 2.55 | 0.23 | 10.16 | 0.15 | 1.06 | 4.61 | 6.41 | 19.88 | 11.88 | 7.24 | 9.05 | 7.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
